CD68 and chronic myelogenous leukemia, BCR-ABL1 positive: Further analyses of CML bone marrow samples revealed that the percentage of CD68+, CD163+, and CD206+ macrophages in BM samples of CML patients was significantly higher than in the control group and was gradually elevated during the progression of CML from chronic phase to blast crisis.